Class I — Serious Health Hazard

Serious health hazard — there is a reasonable probability that use of or exposure to this product will cause serious adverse health consequences or death.

SARS CoV 2 rapid antigen test kits packaged under the Recalled by North American Diagnostics Due to Various brands of SARS CoV 2 Antigen Rapid...

Date: June 15, 2022
Company: North American Diagnostics
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact North American Diagnostics directly.

Affected Products

SARS CoV 2 rapid antigen test kits packaged under the following brands: Oral Rapid Test, Oral Rapid Antigen Test, SML LDT Kits, SML Brand Finished Kits, SML Brand BT Test Kits, SML Brand BT Antigen Test Kit LDT

Quantity: 122,366 units

Why Was This Recalled?

Various brands of SARS CoV 2 Antigen Rapid Test kits were offered for sale and distribution to consumers in the United States without marketing approval, clearance, or authorization from FDA.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About North American Diagnostics

North American Diagnostics has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report